Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 62, Issue 2, Pages 987-992Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b01723
Keywords
-
Categories
Funding
- Musella Foundation Grant from the Department of Neurosurgery, Mitchell Cancer Institute, University of South Alabama
Ask authors/readers for more resources
Human acid ceramidase (AC) is a lysosomal cysteine amidase, which has received a great deal of interest in recent years as a potential target for the development of new therapeutics against melanoma and glioblastoma tumors. Despite the strong interest in obtaining structural information, only the structures of the apo-AC enzyme in its zymogen and activated conformations are available. In this work, the crystal structure of AC in complex with the covalent carmofur inhibitor is presented. Carmofur is an antineoplastic drug containing an electrophilic carbonyl reactive group that targets the catalytic cysteine. This novel structural data explains the basis of the AC inhibition, provides insights into the enzymatic properties of the protein, and is a great aid toward the structure-based drug design of potent inhibitors for AC, providing the detailed mechanism, which has eluded the scientific community for more than 30 years, of carmofur's mysterious 5-fluorouracil-independent antitumor activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available